ARC
GHDX

Absolute Return Capital’s Genomic Health, Inc. GHDX Stock Holding History

Absolute Return Capital’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-23,167
Closed -$610K – 1453
2014
Q1 		$610K Buy
+23,167
New +$665K 0.01% 787

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Absolute Return Capital's GHDX Position: Q2 2014 in Review

Absolute Return Capital sold out of Genomic Health, Inc. (GHDX) in Q2 2014, closing a stake of 23,167 shares — an estimated $610K sold.

Absolute Return Capital first reported a position in GHDX in Q1 2014 and held it in 1 quarter. The position peaked at $610K in Q1 2014. 112 funds tracked by Wall St. Rank hold GHDX as of Q2 2014.

  • Absolute Return Capital reported no remaining Genomic Health, Inc. position as of Q2 2014 after selling out during the quarter.
  • Absolute Return Capital sold 23,167 Genomic Health, Inc. shares in Q2 2014, an estimated $610K.
  • Absolute Return Capital first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 1 quarter.
  • Absolute Return Capital's Genomic Health, Inc. position peaked at $610K in Q1 2014.
  • 112 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2014.

Based on Absolute Return Capital's 13F filing for Q2 2014, filed 14 Aug 2014.